Previous research has demonstrated that a direct interaction between abundant tumor-infiltrating B-cells (TIL-B) and a higher density of B cells/CD8+ T cells leads to better prognoses for patients [48], and increased infiltration of CD8+ T cells has been closely associated with improved OS and local control (LRC) [42]. The gene discussed is CD8A; the disease is neoplasm.